AFP — AFT Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- AU$341.41m
- AU$376.76m
- NZ$254.71m
Annual cashflow statement for AFT Pharmaceuticals, fiscal year end - March 31st, NZD millions except per share, conversion factor applied.
R2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash from Operating Activities | 14.2 | 11.6 | 28.9 | 13.2 | -9.54 |
| Capital Expenditures | -5.58 | -9.18 | -9.53 | -6.95 | -9.76 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Cash from Investing Activities | -5.58 | -9.18 | -9.53 | -6.95 | -9.76 |
| Financing Cash Flow Items | -2.19 | -2.86 | -3.62 | -2.8 | -2.48 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -2.28 | -6.98 | -10.6 | -6.81 | 8.79 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 6.39 | -4.65 | 8.75 | -0.93 | -10.8 |